26 May, 2010
Ken Duckworth, M.D., medical director of the National Alliance on Mental Illness (NAMI), has been honored with the Patient Advocacy Award of the American Psychiatric Association (APA) at the organization's 2010 Annual Meeting in New Orleans. Dr...
26 May, 2010
The National Alliance on Mental Illness (NAMI) has honored 22 doctors as "Exemplary Psychiatrists" at the American Psychiatric Association (APA) annual conference in New Orleans. "We are proud to honor these psychiatrists for their exceptional dedication to people living with mental illness," said NAMI Executive Director Michael J. Fitzpatrick...
26 May, 2010
Physician-scientists from NewYork-Presbyterian Hospital/Weill Cornell Medical Center are presenting their latest research findings at the American Psychiatric Association Annual Meeting in New Orleans, May 22 to 26. Among the most significant presentations are the following: Funding for at-risk suicide patients better directed to post-hospital discharge care [SCR54] Tuesday, May 25 Dr...
26 May, 2010
Clinical Data, Inc. (NASDAQ: CLDA), announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for vilazodone for the treatment of major depressive disorder (MDD). Vilazodone is a dual-acting potent and selective serotonin reuptake inhibitor and a 5-HT1A receptor partial agonist. The NDA will be subject to a standard review...
26 May, 2010
According to a national survey by the Substance Abuse and Mental Health Services Administration (SAMHSA) there are an estimated 9.8 million adults aged 18 or older living with serious mental illness. Among adults, the prevalence of serious mental illness is highest in the 18 to 25 age group, yet this age group is also the least likely to receive services or counseling for mental health issues...
25 May, 2010
New data on INVEGA® SUSTENNA® (paliperidone palmitate), a long-acting injectable medicine for schizophrenia, and new data on RISPERDAL® CONSTA® (risperidone long-acting therapy), also an injectable medicine to treat schizophrenia, will be presented next week at a major psychiatry meeting in New Orleans...
25 May, 2010
According to a new survey sponsored by Janssen,® Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, 80 percent of patients with schizophrenia, a chronic, severe and disabling brain disorder, say their psychiatrists do well or very well in treating them with courtesy and respect...
25 May, 2010
Jackson Clarion Ledger: "Lawmakers earlier this year vigorously fought Gov. Haley Barbour's proposal to close four state mental health hospitals and six crisis centers as a budget-saving measure. Now, nonprofit-run centers that offer front-line services for the mentally ill in some of the poorest communities across Mississippi could face closure...